Jennifer K Litton

Jennifer K Litton

UNVERIFIED PROFILE

Are you Jennifer K Litton?   Register this Author

Register author
Jennifer K Litton

Jennifer K Litton

Publications by authors named "Jennifer K Litton"

Are you Jennifer K Litton?   Register this Author

85Publications

1951Reads

40Profile Views

The implications of genetic testing on radiotherapy decisions: a guide for radiation oncologists.

Int J Radiat Oncol Biol Phys 2019 Aug 2. Epub 2019 Aug 2.

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd. Unit 1202, Houston, TX, 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2019.07.026DOI Listing
August 2019

Integrating poly(ADP-ribose) polymerase (PARP) inhibitors in the treatment of early breast cancer.

Curr Opin Oncol 2019 May;31(3):247-255

Division of Cancer Medicine, Department of Breast Medical Oncology, Clinical Cancer Genetics, The University of Texas MD Anderson Cancer Center, Houston, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000516DOI Listing
May 2019

Molecular Testing in Breast Cancer.

Am Soc Clin Oncol Educ Book 2019 Jan 17;39:e1-e7. Epub 2019 May 17.

3 Institute of Cancer Research, NHS Royal Marsden Hospital, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_237715DOI Listing
January 2019

Breast cancer in adolescents and young adults.

Pediatr Blood Cancer 2018 12 28;65(12):e27397. Epub 2018 Aug 28.

Oregon Health and Science University, Portland, Oregon.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.27397DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192832PMC
December 2018

Prognostic Factors in Patients with Metastatic Breast Cancer with Bone-Only Metastases.

Oncologist 2018 Nov 17;23(11):1282-1288. Epub 2018 Aug 17.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2018-0085DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6291319PMC
November 2018

Impact of change in body mass index during neoadjuvant chemotherapy and survival among breast cancer subtypes.

Breast Cancer Res Treat 2018 Sep 18;171(2):501-511. Epub 2018 Jun 18.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe, Unit 1354, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-018-4853-4DOI Listing
September 2018

Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation.

N Engl J Med 2018 08 15;379(8):753-763. Epub 2018 Aug 15.

From the University of Texas M.D. Anderson Cancer Center, Houston (J.K.L.), and the Texas Oncology-Baylor Charles A. Sammons Cancer Center, US Oncology Network, Dallas (J.L.B.) - both in Texas; University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center (H.S.R.), and Pfizer (R.G.W.Q., D.M., I.C.T., A.L.H.), San Francisco, University of California, Los Angeles, Los Angeles (S.A.H.), and Kaiser Permanente, Northern California, Vallejo (L.F.) - all in California; the Department of Obstetrics and Gynecology, Klinikum Rechts der Isar, Technische Universität München (J.E.), and Interdisziplinäres Onkologisches Zentrum München (W.E.) - both in Munich, Germany; Institut Paoli-Calmettes, Marseille (A.G.), and Institut Claudius Regaud, Institut Universitaire du Cancer Toulouse, Toulouse (H.R.) - both in France; Seoul National University Hospital (K.-H.L.) and Samsung Medical Center (Y.-H.I.) - both in Seoul, South Korea; Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel (R.Y.); Banner M.D. Anderson Cancer Center, Gilbert, AZ (L.A.M.); and Instituto de Investigación Sanitaria Gregorio Marañón, Centro de Investigación Biomédica en Red Oncología, Grupo Español de Investigación en Cáncer de Mama, Universidad Complutense, Madrid (M.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1802905DOI Listing
August 2018

Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1.

Mol Cell 2018 08;71(4):606-620.e7

Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Graduate School of Biomedical Sciences, University of Texas Health Science Center, Houston, TX 77030, USA; Graduate Institute of Biomedical Sciences and Center for Molecular Medicine, China Medical University, Taichung 404, Taiwan; Department of Biotechnology, Asia University, Taichung 413, Taiwan. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10972765183059
Publisher Site
http://dx.doi.org/10.1016/j.molcel.2018.07.030DOI Listing
August 2018

Phase Ib trial of folate binding protein (FBP)-derived peptide vaccines, E39 and an attenuated version, E39': An analysis of safety and immune response.

Clin Immunol 2018 07 21;192:6-13. Epub 2018 Mar 21.

Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1400 Pressler St, Unit 1434, Houston, TX 77030, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clim.2018.03.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5988975PMC
July 2018

BRCA mutations in women with inflammatory breast cancer.

Cancer 2018 02 17;124(3):466-474. Epub 2017 Oct 17.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31069DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780239PMC
February 2018

Characterization of bone only metastasis patients with respect to tumor subtypes.

NPJ Breast Cancer 2018 25;4. Epub 2018 Jan 25.

3Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41523-018-0054-x
Publisher Site
http://dx.doi.org/10.1038/s41523-018-0054-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785511PMC
January 2018

Systemic Treatment Strategies for Patients with Hereditary Breast Cancer Syndromes.

Oncologist 2017 06 3;22(6):655-666. Epub 2017 May 3.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston Texas, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2016-0430DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469585PMC
June 2017

Erratum to: Rates of BRCA1/2 mutation testing among young survivors of breast cancer.

Breast Cancer Res Treat 2016 08;159(1):201

Department of Health Services Research, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-016-3922-9DOI Listing
August 2016

Cancer Incidence in First- and Second-Degree Relatives of BRCA1 and BRCA2 Mutation Carriers.

Oncologist 2016 07 15;21(7):869-74. Epub 2016 Jun 15.

Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2015-0354DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943383PMC
July 2016

Evaluation of BRCAPRO Risk Assessment Model in Patients with Ductal Carcinoma In situ Who Underwent Clinical BRCA Genetic Testing.

Front Genet 2016 27;7:71. Epub 2016 Apr 27.

Clinical Cancer Genetics, The University of Texas MD Anderson Cancer CenterHouston, TX, USA; Departments of Breast Medical Oncology, The University of Texas MD Anderson Cancer CenterHouston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fgene.2016.00071DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847480PMC
May 2016

Rates of BRCA1/2 mutation testing among young survivors of breast cancer.

Breast Cancer Res Treat 2016 Jan 26;155(1):165-73. Epub 2015 Dec 26.

Department of Health Services Research, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-015-3658-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5521172PMC
January 2016

Phase II Randomized Study of Ixabepilone Versus Observation in Patients With Significant Residual Disease After Neoadjuvant Systemic Therapy for HER2-Negative Breast Cancer.

Clin Breast Cancer 2015 Oct 24;15(5):325-31. Epub 2015 Mar 24.

Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2015.03.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568133PMC
October 2015

Reply to BRCA2-associated pancreatic cancer and current screening guidelines.

Cancer 2015 Sep 27;121(17):3047. Epub 2015 May 27.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29446DOI Listing
September 2015

BRCAPRO 6.0 Model Validation in Male Patients Presenting for BRCA Testing.

Oncologist 2015 Jun 6;20(6):593-7. Epub 2015 May 6.

University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Baylor Charles A. Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas, USA; University of Texas Health and Science Center at Houston, Houston, Texas, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2014-0425DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4571779PMC
June 2015

Predictors that Influence Election of Contralateral Prophylactic Mastectomy among Women with Ductal Carcinoma in Situ who are BRCA-Negative.

J Cancer 2015 23;6(7):610-5. Epub 2015 May 23.

1. Clinical Cancer Genetics, the University of Texas MD Anderson Cancer Center, Houston, TX ; 2. Department of Breast Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7150/jca.11710DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4466409PMC
June 2015

Is the future of personalized therapy in triple-negative breast cancer based on molecular subtype?

Oncotarget 2015 May;6(15):12890-908

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536987PMC
http://dx.doi.org/10.18632/oncotarget.3849DOI Listing
May 2015

Receptor status change from primary to residual breast cancer after neoadjuvant chemotherapy and analysis of survival outcomes.

Clin Breast Cancer 2015 Apr 2;15(2):153-60. Epub 2014 Oct 2.

Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX; Department of Systems Biology, The University of Texas M.D. Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2014.09.006DOI Listing
April 2015

Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian.

Cancer 2015 Jan 15;121(2):269-75. Epub 2014 Sep 15.

Genetic Counseling Program, University of Texas Graduate School of Biomedical Science at Houston, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29041DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4293332PMC
January 2015

Outcomes of children exposed in utero to chemotherapy for breast cancer.

Breast Cancer Res 2014 Dec 30;16(6):500. Epub 2014 Dec 30.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Box 1354, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13058-014-0500-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303207PMC
December 2014

Reply to D. Crivellari et al.

J Clin Oncol 2014 Jan 2;32(3):256-7. Epub 2013 Dec 2.

University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.53.1020DOI Listing
January 2014

The relationship between body composition and response to neoadjuvant chemotherapy in women with operable breast cancer.

Oncologist 2012 17;17(10):1240-5. Epub 2012 Aug 17.

Division of Hematology/Oncology and Palliative Care, Department of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia 23284, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2012-0169DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481889PMC
June 2013

Breast cancer in the young: role of the geneticist.

J Thorac Dis 2013 Jun;5 Suppl 1:S19-26

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2072-1439.2013.04.13DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3695544PMC
June 2013

Fertility preservation in women with breast cancer: challenges and opportunities.

Oncology (Williston Park) 2013 Jun;27(6):544, 546

The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
June 2013

Impact of body mass index on survival outcome among women with early stage triple-negative breast cancer.

Clin Breast Cancer 2012 Oct;12(5):364-72

Department of Medical Oncology, Dubai Hospital, United Arab Emirates.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2012.07.013DOI Listing
October 2012

Biologic features and prognosis of ductal carcinoma in situ are not adversely impacted by initial large body mass.

Breast Cancer Res Treat 2012 Jun 4;133(3):1131-41. Epub 2012 Mar 4.

Department of Surgical Oncology, DCIS Discovery Enterprise, Unit 1484, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, TX 77230-1402, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-012-1999-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3855009PMC
June 2012

Breast cancer and fertility.

Curr Treat Options Oncol 2012 Jun;13(2):137-45

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-012-0185-5DOI Listing
June 2012

Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer.

Cancer 2012 Mar 28;118(5):1202-11. Epub 2011 Jul 28.

Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.26439DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3207034PMC
March 2012

Early onset HER2-positive breast cancer is associated with germline TP53 mutations.

Cancer 2012 Feb 14;118(4):908-13. Epub 2011 Jul 14.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.26377DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527897PMC
February 2012

Earlier age of onset of BRCA mutation-related cancers in subsequent generations.

Cancer 2012 Jan 12;118(2):321-5. Epub 2011 Sep 12.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030-4009, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.26284
Publisher Site
http://dx.doi.org/10.1002/cncr.26284DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369377PMC
January 2012

Triple-negative breast cancer is not a contraindication for breast conservation.

Ann Surg Oncol 2011 Oct 27;18(11):3164-73. Epub 2011 Sep 27.

Department of Surgical Oncology, The University of Texas, M. D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-011-1920-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4337779PMC
October 2011

Effectiveness of alternating mammography and magnetic resonance imaging for screening women with deleterious BRCA mutations at high risk of breast cancer.

Cancer 2011 Sep 1;117(17):3900-7. Epub 2011 Mar 1.

Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.25971
Publisher Site
http://dx.doi.org/10.1002/cncr.25971DOI Listing
September 2011

Management of local-regional recurrence following immediate breast reconstruction in patients with early breast cancer treated without postmastectomy radiotherapy.

Plast Reconstr Surg 2011 May;127(5):1763-72

Department of Surgical Oncology, Plastic Surgery, Radiation Oncology, and Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PRS.0b013e31820cf24cDOI Listing
May 2011

Breast cancer and pregnancy: current concepts in diagnosis and treatment.

Oncologist 2010 8;15(12):1238-47. Epub 2010 Dec 8.

Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2010-0262DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3227919PMC
April 2011

Sentinel lymph node dissection is technically feasible in older breast cancer patients.

Clin Breast Cancer 2010 Dec;10(6):477-82

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CBC.2010.n.063DOI Listing
December 2010

Clinical application of breast cancer risk assessment models.

Future Oncol 2010 Mar;6(3):355-65

The Univeristy of Texas MD Anderson Cancer Center, Houston, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.10.5DOI Listing
March 2010

Breast cancer diagnosis during pregnancy.

Womens Health (Lond) 2009 May;5(3):243-9

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/whe.09.2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2753540PMC
May 2009

Multifocal breast cancer in women < or =35 years old.

Cancer 2007 Oct;110(7):1445-50

Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.22928DOI Listing
October 2007